Durable Response to Vemurafenib and Cobimetinib for the Treatment of BRAF-Mutated Metastatic Melanoma in Routine Clinical Practice

  1. Álamo, M.C.
  2. Ochenduszko, S.
  3. Crespo, G.
  4. Corral, M.
  5. Oramas, J.
  6. Sancho, P.
  7. Medina, J.
  8. Garicano, F.
  9. López, P.
  10. Balea, B.C.
  11. Garzotto, A.R.
  12. Muñoz-Couselo, E.
Journal:
OncoTargets and Therapy

ISSN: 1178-6930

Year of publication: 2021

Volume: 14

Pages: 5345-5352

Type: Article

DOI: 10.2147/OTT.S325208 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus